Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 255
7
Diseases
8
Unique genes
0.294
Avg. similarity score
Corpus callosum agenesis with abnormal genitalia
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Corpus callosum agenesis with abnormal genitalia
X-linked lissencephaly
X-linked spasticity-intellectual disability-epilepsy syndrome
Arachnoid cysts
Lissencephaly, x-linked
Periventricular heterotopia
Benign mesial temporal lobe epilepsy
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Corpus callosum agenesis with abnormal genitalia | 5 | 5 | 1 |
| X-linked lissencephaly | 5 | 5 | 1 |
| X-linked spasticity-intellectual disability-epilepsy syndrome | 5 | 5 | 1 |
| Arachnoid cysts | 4 | 4 | 3 |
| Lissencephaly, x-linked | 4 | 4 | 2 |
| Periventricular heterotopia | 4 | 4 | 5 |
| Benign mesial temporal lobe epilepsy | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ARX | 6 / 7 | Arachnoid cysts, Corpus callosum agenesis with abnormal genitalia, Lissencephaly, x-linked, Periventricular heterotopia and 2 more |
| CPA6 | 2 / 7 | Benign mesial temporal lobe epilepsy, Periventricular heterotopia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Molybdenum cofactor biosynthesis | Reactome | 1 / 6 | 250× | 3.99e-3 | 3.77e-2 ✓ sig. |
| Spliceosome | KEGG | 2 / 162 | 18.5× | 4.80e-3 | 4.27e-2 ✓ sig. |
| mRNA Splicing - Major Pathway | Reactome | 2 / 183 | 16.4× | 6.09e-3 | 4.98e-2 ✓ sig. |
| VxPx cargo-targeting to cilium | Reactome | 1 / 21 | 71.5× | 1.39e-2 | 8.31e-2 |
| Folate biosynthesis | KEGG | 1 / 28 | 53.6× | 1.85e-2 | 9.85e-2 |
| GABAergic synapse | KEGG | 1 / 89 | 16.9× | 5.78e-2 | 1.85e-1 |
| Biosynthesis of cofactors | KEGG | 1 / 154 | 9.7× | 9.81e-2 | 2.45e-1 |
| Hippo signaling pathway | KEGG | 1 / 157 | 9.6× | 9.99e-2 | 2.48e-1 |
| Tight junction | KEGG | 1 / 170 | 8.8× | 1.08e-1 | 2.59e-1 |
| Human papillomavirus infection | KEGG | 1 / 333 | 4.5× | 2.01e-1 | 3.66e-1 |
| Metabolic pathways | KEGG | 1 / 1,563 | 1.0× | 6.72e-1 | 7.87e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| glycine receptor clustering | GO:0072579 | 1 / 1 | 2,336× | 4.28e-4 | 8.59e-3 ✓ sig. |
| protein localization to myelin sheath abaxonal region | GO:0035750 | 1 / 1 | 2,336× | 4.28e-4 | 8.59e-3 ✓ sig. |
| metanephric distal tubule morphogenesis | GO:0072287 | 1 / 1 | 2,336× | 4.28e-4 | 8.59e-3 ✓ sig. |
| antiviral innate immune response | GO:0140374 | 2 / 79 | 59.1× | 4.86e-4 | 9.37e-3 ✓ sig. |
| establishment of synaptic specificity at neuromuscular junction | GO:0007529 | 1 / 2 | 1,168× | 8.56e-4 | 1.36e-2 ✓ sig. |
| embryonic olfactory bulb interneuron precursor migration | GO:0021831 | 1 / 2 | 1,168× | 8.56e-4 | 1.36e-2 ✓ sig. |
| nitrogen cycle metabolic process | GO:0071941 | 1 / 2 | 1,168× | 8.56e-4 | 1.36e-2 ✓ sig. |
| establishment or maintenance of polarity of embryonic epithelium | GO:0016332 | 1 / 3 | 779× | 1.28e-3 | 1.75e-2 ✓ sig. |
| lymph vessel morphogenesis | GO:0036303 | 1 / 3 | 779× | 1.28e-3 | 1.75e-2 ✓ sig. |
| metanephric proximal tubule development | GO:0072237 | 1 / 3 | 779× | 1.28e-3 | 1.75e-2 ✓ sig. |
| neuron migration | GO:0001764 | 2 / 132 | 35.4× | 1.35e-3 | 1.81e-2 ✓ sig. |
| cerebral cortex tangential migration | GO:0021800 | 1 / 4 | 584× | 1.71e-3 | 2.07e-2 ✓ sig. |
| epithelial cell fate commitment | GO:0072148 | 1 / 4 | 584× | 1.71e-3 | 2.07e-2 ✓ sig. |
| globus pallidus development | GO:0021759 | 1 / 4 | 584× | 1.71e-3 | 2.07e-2 ✓ sig. |
| molybdopterin cofactor biosynthetic process | GO:0032324 | 1 / 4 | 584× | 1.71e-3 | 2.07e-2 ✓ sig. |